FDA authorizes rheumatoid arthritis drug for emergency use to treat severely ill COVID-19 patients

Actemra, which is manufactured by Roche, will be given to hospitalized patients who are already receiving steroid drugs, oxygen and other measures to fight the virus.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news